Early adherence is an especially problematic, significant and modifiable barrier to quality care for depression.
Researchers examined whether the risk of relapse or time to relapse was related to type of anxiety disorder, duration of previous treatment, and other factors.
Scores for both anxiety and depression are associated with low BMD.
In young adults, MDD, GAD, and SSRI use is associated with bone metabolism.
Elevated cytokine levels could help to identify children who are unlikely to respond to treatment with fluoxetine.
Individuals suffering from depression, as well as persons diagnosed with temporal lobe epilepsy, present with dysfunction across several cognitive domains.
Cigarette smoking prevalence among persons with severe mental illness is approximately 3 times greater than the rate observed in the general population.
Depression symptoms at baseline correlated with increased mortality among participants with early- but not late-stage disease.
Approximately 80% of depressive episodes have their onset during the first six months following traumatic brain injury.
Pupillary reactivity to emotional stimuli has been investigated to provide objective information about the risk for recurrence of depressive symptoms in women.
Lower diversity of microbial populations in the human gut has been identified in individuals with major depressive disorder.
Dr. Roger McIntyre suggests that the clinical relevance of cognitive dysfunction for any individual patient can only be adjudicated on a case-by-case basis.
Researchers investigated the lasting effects of whole body hyperthermia (WBH) in the first randomized, double-blind, [placebo]-controlled study of WBH for the treatment of MDD.
Dysfunction across several cognitive domains is often concomitant with depression.
"Detecting depression in the emergency department is of utmost importance," Dr. Brickman and colleagues wrote in their publication.
The registry contains more than 10,000 EEGs and 38,000 pharmacological outcomes, and is accessible to clinicians worldwide.
Brain-derived Neurotrophic Factor and its Precursor proBDNF as Diagnostic Biomarkers for Mood DisordersSeptember 12, 2016
mBDNF/proBDNF ratio could potentially serve as a novel biomarker for mood disorders.
Atrophy of numerous structures within the central nervous system has been observed in persons suffering from depression.
Dementia risk was particularly elevated in patients with depression who had higher scores on cognitive tests at baseline.
The First Baby Study at Penn State College of Medicine includes more than 3 000 women in Pennsylvania having their first baby.
Understanding distinct patterns of comorbid substance use may be more relevant to prevention and treatment than focusing on one individual substance.
Individuals diagnosed with melancholic major depressive disorder presented with more severe symptoms of depression compared with persons with non-melancholic depression.
Sustained anterior cingulate cortex activation during rewarding events predicted better treatment response to Behavioral Activation Treatment for Depression.
Risk highest among patients with psych symptoms pre-ICU/psych distress symptoms while in ICU
Psychosocial and Demographic Predictors of Depression Among Individuals With Bipolar Disorder and SchizophreniaAugust 15, 2016
Bipolar disorder and schizophrenia are characterized by significant genetic overlap, as well as significant clinical presentation overlap.
Grandchildren with both a depressed parent and depressed grandparent were at highest risk for MDD.
An analysis of the SF-36 health survey found that the survey can accurately determine the presence of psychological disorders in patients with RA, and suggests that a threshold of ≤38 on the mental component summary score may be optimal to screen for these disorders.
Childhood is a critical developmental period in the brain's response to traumatic stress such as family adversity.
In terms of depressive and negative symptoms, in the present meta-analysis, researchers estimate that 1 in 9 patients with schizophrenia will improve with add-on antidepressants.
The accuracy of the PHQ-2 in identifying major depression is lower than originally thought.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Efficacy, Safety of Long-Term Ketamine Administration Still In Question
- Etiology of Schizophrenia: Strong Association With Certain Rare Copy Number Variants
- KCNQ Channel Potentiator Ezogabine Delivers Promising Results in Major Depressive Disorder
- Vulnerability to Psychosocial Disability in Psychosis
- FDA to Review Lumateperone for Treatment of Schizophrenia
- Cannabis Use, Cannabis Use Disorder Linked to Psychotic, Depressive Symptoms
- Abstinence From Regular Cannabis Use Improves Memory Among Adolescents, Young Adults
- Association Between Opioid and Benzodiazepine Misuse and Suicidal Ideation
- Group Cognitive Behavioral Therapy Is Effective Treatment for Adolescent Anxiety
- The Intersection of Eating and Alcohol Disorders: Detecting and Managing "Drunkorexia"